Cao W, Adya N, Britos-Bray M, Liu P P, Friedman A D
Division of Pediatric Oncology, Johns Hopkins Oncology Center, Baltimore, Maryland 21287, USA.
J Biol Chem. 1998 Nov 20;273(47):31534-40. doi: 10.1074/jbc.273.47.31534.
We have expressed several variants of core binding factor beta (CBFbeta)-smooth muscle myosin heavy chain (SMMHC) from the metallothionein promoter in Ba/F3 cells. Deletion of amino acids 2-11 from the CBFbeta segment, required for interaction with CBFalpha, prevented CBFbeta-SMMHC from inhibiting CBF DNA binding and cell cycle progression. Deletion of 283 carboxyl-terminal residues from the SMMHC domain, required for multimerization, also inactivated CBFbeta-SMMHC. Nuclear expression of CBFbeta(Delta2-11)-SMMHC was decreased relative to CBFbeta-SMMHC. CBFbeta(Delta2-11)-SMMHC linked to a nuclear localization signal still did not slow cell growth. The ability of each CBFbeta-SMMHC variant to inhibit CBF DNA binding and cell proliferation correlated with its ability to inhibit transactivation by an AML1-VP16 fusion protein. Thus, CBFbeta-SMMHC slows cell cycle progression from G1 to S phase by inhibiting CBF DNA binding and transactivation.
我们已在Ba/F3细胞中从金属硫蛋白启动子表达了几种核心结合因子β(CBFβ)-平滑肌肌球蛋白重链(SMMHC)变体。从CBFβ片段中缺失与CBFα相互作用所需的2-11位氨基酸,会阻止CBFβ-SMMHC抑制CBF DNA结合和细胞周期进程。从SMMHC结构域中缺失多聚化所需的283个羧基末端残基,也会使CBFβ-SMMHC失活。相对于CBFβ-SMMHC,CBFβ(Δ2-11)-SMMHC的核表达降低。与核定位信号相连的CBFβ(Δ2-11)-SMMHC仍不会减缓细胞生长。每个CBFβ-SMMHC变体抑制CBF DNA结合和细胞增殖的能力与其抑制AML1-VP16融合蛋白反式激活的能力相关。因此,CBFβ-SMMHC通过抑制CBF DNA结合和反式激活来减缓细胞周期从G1期到S期的进程。